Clinical Trials Logo

Clinical Trial Summary

It is currently not allowed for patients with prolonged aplasia, following intensive chemotherapy, to brush teeth due to the risk of damaging the oral mucosa with risk of haemorrhage and infectious entrance door. Mouthwash is currently prescribed to prevent these complications. Many patients, however, ask to brush their teeth for greater comfort and a feeling of well-being.

Some haematology services allow tooth brushing while others prohibit tooth brushing without study.

Investigators wanted to conduct a study to assess the feasibility, the safety of tooth brushing for aplastic patient comfort, hemopathy and/or chemotherapies causing mucous membrane alteration that increases infectious risk and the risk of gingivorragia.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT03879252
Study type Interventional
Source University Hospital, Angers
Contact Amandine Valette
Phone 0241353637
Email Amandine.Valette@chu-angers.fr
Status Not yet recruiting
Phase Phase 3
Start date June 2019
Completion date January 2022

See also
  Status Clinical Trial Phase
Recruiting NCT03959007 - Impact of Supportive Care on the Experience of Hospitalization of Patients Staying in the Protected Area of the Department of Blood Diseases N/A
Recruiting NCT04794608 - Hypnosis in Virtual Reality in Patients in Protector Isolation Room for Aplasia in Clinical Hematology. N/A
Not yet recruiting NCT05790733 - HYPNONAG : Therapeutic Communication Versus Traditional Method for Naso-gastric Intubation in Haematology N/A